Gabriele de RubisGabriele holds a Bachelor's Degree in Biotechnology ("La Sapienza" University of Rome, Italy) and a Master's
degree in Genetic Sciences and Technologies (University of Sannio, Benevento, Italy). He has just
completed a PhD in Pharmacy (thesis uder examination) at the Discipline of Pharmacy, Graduate School
of Health, UTS, with a thesis on the development of advanced drug delivery systems for respiratory diseases.
Gabriele has extensive experience as an industry-based researcher, particularly in the setup and
evaluation of animal (mouse and rat) models of cancer and inflammatory diseases and in the preclinical
in vivo testing of the safety, efficacy and pharmacokinetic properties of novel anti-cancer and anti-inflammatory
drugs.
Gabriele's current expertise and research interest cover the in vitro advanced
drug delivery of phytoceuticals and nucleic acid-based therapeutics (decoy oligodeoxynucleotides,
miRNAs) for the treatment of respiratory inflammatory diseases and lung cancer. Read More Read Less